Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 26, Pages 3749-3759
Publisher
Springer Nature
Online
2017-02-21
DOI
10.1038/onc.2017.1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
- (2016) Sophia Frentzas et al. NATURE MEDICINE
- Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models
- (2016) Yuji Piao et al. NEURO-ONCOLOGY
- MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis
- (2016) A Ghoochani et al. ONCOGENE
- New tools for studying microglia in the mouse and human CNS
- (2016) Mariko L. Bennett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
- (2016) N. N. Rahbari et al. Science Translational Medicine
- Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells
- (2016) Yashi Gupta et al. PLoS One
- Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer
- (2015) D. L. Moughon et al. CANCER RESEARCH
- Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
- (2015) A. Scholz et al. EMBO Molecular Medicine
- Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions
- (2015) Michael Thiele et al. JOURNAL OF IMMUNOLOGY
- M2 polarization enhances silica nanoparticle uptake by macrophages
- (2015) Jessica Hoppstädter et al. Frontiers in Pharmacology
- Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes
- (2015) Konrad Gabrusiewicz et al. Oncotarget
- MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas
- (2014) Pia S. Zeiner et al. BRAIN PATHOLOGY
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- 1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma
- (2013) W. S. Carbonell et al. CANCER RESEARCH
- Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis
- (2013) Shilpa Choudhary et al. CARCINOGENESIS
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
- (2013) Y. Piao et al. CLINICAL CANCER RESEARCH
- Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor
- (2013) K. Yaddanapudi et al. JOURNAL OF IMMUNOLOGY
- Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
- (2013) C. Lu-Emerson et al. NEURO-ONCOLOGY
- Distribution of macrophage polarization markers in human atherosclerosis
- (2012) J. Lauran Stöger et al. ATHEROSCLEROSIS
- Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy
- (2012) Yu-Long Hu et al. Autophagy
- Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model
- (2012) E Girard et al. BRITISH JOURNAL OF CANCER
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- MIF Produced by Bone Marrow-Derived Macrophages Contributes to Teratoma Progression after Embryonic Stem Cell Transplantation
- (2012) X. Wang et al. CANCER RESEARCH
- Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy
- (2012) M. DeLay et al. CLINICAL CANCER RESEARCH
- Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
- (2012) Y. Piao et al. NEURO-ONCOLOGY
- Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression
- (2011) Michel Mittelbronn et al. ACTA NEUROPATHOLOGICA
- DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
- (2011) J.-L. Li et al. CANCER RESEARCH
- High-Dose Antiangiogenic Therapy for Glioblastoma: Less May Be More?
- (2011) J. F. de Groot CLINICAL CANCER RESEARCH
- The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout Adulthood
- (2011) M. Mizutani et al. JOURNAL OF IMMUNOLOGY
- Neurosurgical Management and Prognosis of Patients With Glioblastoma That Progresses During Bevacizumab Treatment
- (2011) Aaron J. Clark et al. NEUROSURGERY
- Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation
- (2011) S. J. Jenkins et al. SCIENCE
- Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation
- (2010) Elizabeth F. Redente et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice
- (2010) Noah Saederup et al. PLoS One
- MIF Deficiency Reduces Chronic Inflammation in White Adipose Tissue and Impairs the Development of Insulin Resistance, Glucose Intolerance, and Associated Atherosclerotic Disease
- (2009) Lars Verschuren et al. CIRCULATION RESEARCH
- The Dexamethasone-induced Inhibition of Proliferation, Migration, and Invasion in Glioma Cell Lines Is Antagonized by Macrophage Migration Inhibitory Factor (MIF) and Can Be Enhanced by Specific MIF Inhibitors
- (2009) Caroline Piette et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro
- (2009) M. Leidi et al. JOURNAL OF IMMUNOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation